The use of boron dipyrromethene (BODIPY) in biomedicine is reviewed. To open, its
synthesis and regulatory strategies are summarized, and inspiring cutting‐edge work in post …

In recent years, BODIPY-based theranostics have increasingly been used in cancer therapy
and have achieved significant success. According to photochemical theories, the optical …

Photoactivatable (alternatively, photoremovable, photoreleasable, or photocleavable)
protecting groups (PPGs), also known as caged or photocaged compounds, are used to …

Optical imaging, especially fluorescence and photoacoustic imaging, is a non‐invasive
imaging approach with high spatial and temporal resolution and high sensitivity, compared …

Photodynamic therapy (PDT) is a promising therapeutic approach for anticancer and
antibacterial treatment via photoinduced reactive oxygen species (ROS) generation …

Organic solar cells (OSCs) are emerging as a new photovoltaic technology with the great
advantages of low cost, light-weight, flexibility and semi-transparency. They are promising …

Difluoro-4-bora-3a, 4a-diaza-s-indacene (BODIPY)-based-π-conjugated derivatives are
endowed with extraordinary photonic and electronic properties. The BODIPYs possess …

Boron-dipyrromethene (BODIPY) platforms have been recognized as potential candidates
for a wide range of applications, especially for constructing fluorescent probes due to their …

The BODIPY chromophore is one of the most versatile fluorophore building blocks in various
research fields, especially in life science and material science. It has attracted substantial …

Boron-containing compounds (BCC) have emerged as important pharmacophores. To date,
five BCC drugs (including boronic acids and boroles) have been approved by the FDA for …